These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32735693)

  • 1. Shear-dependent platelet aggregation size.
    Chan CHH; Inoue M; Ki KK; Murashige T; Fraser JF; Simmonds MJ; Tansley GD; Watanabe N
    Artif Organs; 2020 Dec; 44(12):1286-1295. PubMed ID: 32735693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of shear stress on the size, structure, and function of human von Willebrand factor.
    Chan CH; Pieper IL; Fleming S; Friedmann Y; Foster G; Hawkins K; Thornton CA; Kanamarlapudi V
    Artif Organs; 2014 Sep; 38(9):741-50. PubMed ID: 25234758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
    Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
    JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.
    Bartoli CR; Restle DJ; Zhang DM; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):281-9. PubMed ID: 25439775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent.
    Jilma-Stohlawetz P; Quehenberger P; Schima H; Stoiber M; Knöbl P; Steinlechner B; Felli A; Jilma B
    Thromb Res; 2016 Jan; 137():196-201. PubMed ID: 26616301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand factor disruption and continuous-flow circulatory devices.
    Proudfoot AG; Davidson SJ; Strueber M
    J Heart Lung Transplant; 2017 Nov; 36(11):1155-1163. PubMed ID: 28756118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High shear dependent von Willebrand factor self-assembly fostered by platelet interaction and controlled by ADAMTS13.
    Kragh T; Napoleone M; Fallah MA; Gritsch H; Schneider MF; Reininger AJ
    Thromb Res; 2014 Jun; 133(6):1079-87. PubMed ID: 24681085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood.
    Donadelli R; Orje JN; Capoferri C; Remuzzi G; Ruggeri ZM
    Blood; 2006 Mar; 107(5):1943-50. PubMed ID: 16293606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD management.
    Bartoli CR; Kang J; Motomura T
    J Card Surg; 2020 Jul; 35(7):1477-1483. PubMed ID: 32652785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation.
    Deconinck SJ; Nix C; Barth S; Bennek-Schöpping E; Rauch A; Schelpe AS; Roose E; Feys HB; Pareyn I; Vandenbulcke A; Muia J; Vandenbriele C; Susen S; Meyns B; Tersteeg C; Jacobs S; De Meyer SF; Vanhoorelbeke K
    J Thromb Haemost; 2022 Dec; 20(12):2797-2809. PubMed ID: 36128768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolysis and von Willebrand factor degradation in mechanical shuttle shear flow tester.
    Shiraishi Y; Tachizaki Y; Inoue Y; Hayakawa M; Yamada A; Kayashima M; Matsumoto M; Horiuchi H; Yambe T
    J Artif Organs; 2021 Jun; 24(2):111-119. PubMed ID: 33559766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets.
    Alevriadou BR; Moake JL; Turner NA; Ruggeri ZM; Folie BJ; Phillips MD; Schreiber AB; Hrinda ME; McIntire LV
    Blood; 1993 Mar; 81(5):1263-76. PubMed ID: 8443388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devices.
    Rauch A; Legendre P; Christophe OD; Goudemand J; van Belle E; Vincentelli A; Denis CV; Susen S; Lenting PJ
    Thromb Haemost; 2014 Nov; 112(5):1014-23. PubMed ID: 25030452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical Effect of Nonphysiological Shear Stress on Platelets and von Willebrand Factor.
    Chen Z; Mondal NK; Ding J; Koenig SC; Slaughter MS; Wu ZJ
    Artif Organs; 2016 Jul; 40(7):659-68. PubMed ID: 26582038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shear stress and von Willebrand factor in health and disease.
    Tsai HM
    Semin Thromb Hemost; 2003 Oct; 29(5):479-88. PubMed ID: 14631548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation.
    Kang J; Zhang DM; Restle DJ; Kallel F; Acker MA; Atluri P; Bartoli CR
    J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1747-1754.e1. PubMed ID: 26971377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation-independent platelet adhesion and aggregation under elevated shear stress.
    Ruggeri ZM; Orje JN; Habermann R; Federici AB; Reininger AJ
    Blood; 2006 Sep; 108(6):1903-10. PubMed ID: 16772609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual Variability in von Willebrand Factor Fragility in Response to Shear Stress: A Possible Clue for Predicting Bleeding Risk.
    Sakatsume K; Akiyama M; Sakota D; Hijikata W; Horiuchi H; Maruyama O; Saiki Y
    ASAIO J; 2022 Sep; 68(9):1128-1134. PubMed ID: 34967782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Models for Translational Investigations of Left Ventricular Assist Device-Associated von Willebrand Factor Degradation.
    Restle DJ; Zhang DM; Hung G; Howard JL; Kallel F; Acker MA; Atluri P; Bartoli CR
    Artif Organs; 2015 Jul; 39(7):569-75. PubMed ID: 25810063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
    Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
    Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.